Arrhythmia Endpoints in Interventional Cardiovascular Trials: A Missed Opportunity?

References

• Krall R. The State of Clinical Research in the United States: An Overview. National Academies Press (US); 2010.
   Google Scholar
• Mensah GA, Wei GS, Sorlie PD, et al. Decline in cardiovascular mortality: possible causes and implications. Circ Res. 2017;120(2):366–380. doi:10.1161/CIRCRESAHA.116.309115.
   PubMed Web of Science ®Google Scholar
• Lansky AJ, Messe SR, Brickman AM, et al. Proposed standardized neurological endpoints for cardiovascular clinical trials: an academic research consortium initiative. J Am Coll Cardiol. 2017;69(6):679–691. doi:10.1016/j.jacc.2016.11.045.
   Web of Science ®Google Scholar
• Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736–2747. doi:10.1161/CIRCULATIONAHA.110.009449.
   PubMed Web of Science ®Google Scholar
• Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344–2351. doi:10.1161/CIRCULATIONAHA.106.685313.
   PubMed Web of Science ®Google Scholar
• Hicks KA, Tcheng JE, Bozkurt B, et al. 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association task force on clinical data standards (writing committee to develop cardiovascular endpoints data standards). J Am Coll Cardiol. 2015;66(4):403–469. doi:10.1016/j.jacc.2014.12.018.
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60(15):1438–1454. doi:10.1016/j.jacc.2012.09.001.
   PubMed Web of Science ®Google Scholar
• Stone GW, Adams DH, Abraham WT, et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the mitral valve academic research consortium. J Am Coll Cardiol. 2015;66(3):308–321. doi:10.1016/j.jacc.2015.05.049.
   Web of Science ®Google Scholar
• Stone GW, Vahanian AS, Adams DH, et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: a consensus document from the mitral valve academic research consortium. J Am Coll Cardiol. 2015;66(3):278–307. doi:10.1016/j.jacc.2015.05.046.
   Web of Science ®Google Scholar
• John RM, Tedrow UB, Koplan BA, et al. Ventricular arrhythmias and sudden cardiac death. Lancet. 2012;380(9852):1520–1529. doi:10.1016/S0140-6736(12)61413-5.
   Web of Science ®Google Scholar
• Mendis SPPNB. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: World Health Organization; 2011.
   Google Scholar
• Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on clinical cardiology committee on electrocardiography and arrhythmias and council on epidemiology and prevention. Circulation. 2008;118(14):1497–1518.
   PubMed Web of Science ®Google Scholar
• Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation. 1992;85:I2–10.
   PubMed Web of Science ®Google Scholar
• Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346(12):877–883. doi:10.1056/NEJMoa013474.
   PubMed Web of Science ®Google Scholar
• Every N, Hallstrom A, McDonald KM, et al. Risk of sudden versus nonsudden cardiac death in patients with coronary artery disease. Am Heart J. 2002;144(3):390–396.
   Web of Science ®Google Scholar
• Wise RA, Kowey PR, Austen G, et al. Discordance in investigator-reported and adjudicated sudden death in TIOSPIR. ERJ Open Res. 2017;3:1. doi:10.1183/23120541.00073-2016.
   Google Scholar
• Boehmer JP, Carlson MD, De Marco T, et al. Adjudication of mortality events in a heart failure-arrhythmia trial by a multiparameter descriptive method: comparison with methods used in heart failure trials and methods used in arrhythmia trials. J Interv Card Electrophysiol. 2008;23(2):101–110. doi:10.1007/s10840-008-9277-3.
   Web of Science ®Google Scholar
• Epstein AE, Carlson MD, Fogoros RN, Higgins SL, Venditti FJ Jr. Classification of death in antiarrhythmia trials. J Am Coll Cardiol. 1996;27:433–442. doi:10.1016/0735-1097(95)00482-3.
   PubMed Web of Science ®Google Scholar
• Cannon CP, Brindis RG, Chaitman BR, et al. ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on clinical data standards (writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards). J Am Coll Cardiol. 2013;61(9):992–1025. doi:10.1016/j.jacc.2012.10.005.
   Web of Science ®Google Scholar
• Mehta RH, Starr AZ, Lopes RD, et al. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009;301(17):1779–1789. doi:10.1001/jama.2009.600.
   PubMed Web of Science ®Google Scholar
• Kosmidou I, Redfors B, Dordi R, et al. Incidence, predictors, and outcomes of high-grade atrioventricular block in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial). Am J Cardiol. 2017;119(9):1295–1301. doi:10.1016/j.amjcard.2017.01.019.
   Web of Science ®Google Scholar
• Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120–129. doi:10.1056/NEJMoa1105575.
   PubMed Web of Science ®Google Scholar
• Darkner S, Chen X, Hansen J, et al. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial). Eur Heart J. 2014;35(47):3356–3364. doi:10.1093/eurheartj/ehu354.
   Web of Science ®Google Scholar
• Kosmidou I, Redfors B, McAndrew T, et al. Worsening atrioventricular conduction after hospital discharge in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the HORIZONS-AMI trial. Coron Artery Dis. 2017;28(7):550–556. doi:10.1097/MCA.0000000000000525.
   Web of Science ®Google Scholar
• Xu B, Gao R, Yang Y, et al. Biodegradable polymer-based sirolimus-eluting stents with differing elution and absorption kinetics: the PANDA III trial. J Am Coll Cardiol. 2016;67(19):2249–2258. doi:10.1016/j.jacc.2016.03.475.
   Web of Science ®Google Scholar
• Ioanna Kosmidou SC, Pieter Kappetein A, Serruys PW, et al. New-onset atrial fibrillation after PCI and CABG for left main disease: analysis from the EXCEL trial. J Am Coll Cardiol. 2017;71(7):739–748. doi:10.1016/j.jacc.2017.12.012.
   Web of Science ®Google Scholar
• d’Arcy JL, Prendergast BD, Chambers JB, Ray SG, Bridgewater B. Valvular heart disease: the next cardiac epidemic. Heart. 2011;97(2):91–93. doi:10.1136/hrt.2010.205096.
   PubMed Web of Science ®Google Scholar
• Biviano AB, Nazif T, Dizon J, et al. Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement: insights from the placement of aortic transcatheter valve (PARTNER) trial. Circ Cardiovasc Interv. 2016;9(1):e002766. doi:10.1161/CIRCINTERVENTIONS.115.002766.
   PubMed Web of Science ®Google Scholar
• Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, et al. Impact of new-onset left bundle branch block and periprocedural permanent pacemaker implantation on clinical outcomes in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. Circ Cardiovasc Interv. 2016;9(5):e003635. doi:10.1161/CIRCINTERVENTIONS.115.003635.
   PubMed Web of Science ®Google Scholar
• Steinberg BA, Harrison JK, Frazier-Mills C, Hughes GC, Piccini JP. Cardiac conduction system disease after transcatheter aortic valve replacement. Am Heart J. 2012;164(5):664–671. doi:10.1016/j.ahj.2012.07.028.
   Web of Science ®Google Scholar
• Krasopoulos G, Falconieri F, Benedetto U, et al. European real world trans-catheter aortic valve implantation: systematic review and meta-analysis of European national registries. J Cardiothorac Surg. 2016;11(1):159. doi:10.1186/s13019-016-0552-6.
   Web of Science ®Google Scholar
• El-Chami MF, Merchant FM, Smith P, et al. Management of new-onset postoperative atrial fibrillation utilizing insertable cardiac monitor technology to observe recurrence of AF (MONITOR-AF). Pacing Clin Electrophysiol. 2016;39(10):1083–1089. doi:10.1111/pace.12949.
   PubMed Web of Science ®Google Scholar
• Jorgensen TH, Thyregod HG, Tarp JB, Svendsen JH, Sondergaard L. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement. Int J Cardiol. 2017;234:16–21. doi:10.1016/j.ijcard.2017.02.098.
   PubMed Web of Science ®Google Scholar